{ "cik": 914475, "cik_padded": "0000914475", "entityName": "NEUROCRINE BIOSCIENCES INC", "fiscal_years": [ { "accn": "0000914475-26-000007", "filed": "2026-02-11", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 167700000.0, "capex": 34000000.0, "cash": 713000000.0, "eps_diluted": 4.67, "free_cash_flow": 748700000.0, "net_income": 478600000.0, "operating_cash_flow": 782700000.0, "operating_income": 619100000.0, "revenue": 2860500000.0, "stockholders_equity": 3253100000.0, "total_assets": 4631500000.0, "total_liabilities": 1378400000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4237189142663921, "net_margin": 0.16731340674707218, "operating_margin": 0.21643069393462683, "revenue_growth_yoy": 0.21449496879378424, "roa_avg2y": 0.11463198486263802, "roa_period_end": 0.10333585231566447, "roe_avg2y": 0.16382556308619156, "roe_period_end": 0.14712120746365007 } }, { "accn": "0000914475-26-000007", "filed": "2026-02-11", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 300000000.0, "capex": 38200000.0, "cash": 233000000.0, "eps_diluted": 3.29, "free_cash_flow": 557200000.0, "net_income": 341300000.0, "operating_cash_flow": 595400000.0, "operating_income": 570500000.0, "revenue": 2355300000.0, "stockholders_equity": 2589700000.0, "total_assets": 3718700000.0, "total_liabilities": 1129000000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.43595783295362395, "net_margin": 0.14490723050142232, "operating_margin": 0.24221967477603706, "revenue_growth_yoy": 0.2481055587939166, "roa_avg2y": 0.09793259781064834, "roa_period_end": 0.09177938526904564, "roe_avg2y": 0.14156832652384013, "roe_period_end": 0.13179132718075454 } }, { "accn": "0000914475-26-000007", "filed": "2026-02-11", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 28300000.0, "cash": 251100000.0, "eps_diluted": 2.47, "free_cash_flow": 361600000.0, "net_income": 249700000.0, "operating_cash_flow": 389900000.0, "operating_income": 250900000.0, "revenue": 1887100000.0, "stockholders_equity": 2232000000.0, "total_assets": 3251400000.0, "total_liabilities": 1019400000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4567204301075269, "net_margin": 0.132319431932595, "operating_margin": 0.13295532828149012, "revenue_growth_yoy": 0.2676160408410022, "roa_avg2y": 0.08885962883222719, "roa_period_end": 0.0767976871501507, "roe_avg2y": 0.12675770343672269, "roe_period_end": 0.11187275985663084 } }, { "accn": "0000914475-26-000007", "filed": "2026-02-11", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 16500000.0, "cash": 262900000.0, "eps_diluted": 1.56, "free_cash_flow": 322900000.0, "net_income": 154500000.0, "operating_cash_flow": 339400000.0, "operating_income": 249000000.0, "revenue": 1488700000.0, "stockholders_equity": 1707800000.0, "total_assets": 2368700000.0, "total_liabilities": 660900000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.38698910879494086, "net_margin": 0.10378182306710552, "operating_margin": 0.16726002552562635, "revenue_growth_yoy": 0.3133656815174239, "roa_avg2y": 0.06957579032693867, "roa_period_end": 0.06522565120108076, "roe_avg2y": 0.10026607826594847, "roe_period_end": 0.09046726782995666 } }, { "accn": "0000914475-25-000037", "filed": "2025-02-10", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 23400000.0, "cash": 340800000.0, "eps_diluted": 0.92, "free_cash_flow": 233100000.0, "net_income": 89600000.0, "operating_cash_flow": 256500000.0, "operating_income": 102500000.0, "revenue": 1133500000.0, "stockholders_equity": 1374000000.0, "total_assets": 2072500000.0, "total_liabilities": 698500000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5083697234352256, "net_margin": 0.07904719894133215, "operating_margin": 0.09042787825319806, "revenue_growth_yoy": 0.08375561717181375, "roa_avg2y": 0.0470687119142677, "roa_period_end": 0.043232810615199034, "roe_avg2y": 0.0716742660587153, "roe_period_end": 0.06521106259097526 } }, { "accn": "0000914475-24-000054", "filed": "2024-02-09", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 10900000.0, "cash": 187100000.0, "eps_diluted": 4.16, "free_cash_flow": 217600000.0, "net_income": 407300000.0, "operating_cash_flow": 228500000.0, "operating_income": 163000000.0, "revenue": 1045900000.0, "stockholders_equity": 1126200000.0, "total_assets": 1734700000.0, "total_liabilities": 608500000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5403125554963595, "net_margin": 0.38942537527488286, "operating_margin": 0.15584663925805525, "revenue_growth_yoy": 0.3271158482426088, "roa_avg2y": 0.26789883908310586, "roa_period_end": 0.2347956418977345, "roe_avg2y": 0.46202711133798424, "roe_period_end": 0.36165867519090755 } }, { "accn": "0000914475-23-000011", "filed": "2023-02-09", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 14700000.0, "cash": 112300000.0, "eps_diluted": 0.39, "free_cash_flow": 132300000.0, "net_income": 37000000.0, "operating_cash_flow": 147000000.0, "operating_income": 72300000.0, "revenue": 788100000.0, "stockholders_equity": 636900000.0, "total_assets": 1306000000.0, "total_liabilities": 669100000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.050557387344952, "net_margin": 0.04694835680751173, "operating_margin": 0.09173962695089456, "revenue_growth_yoy": 0.7466755319148937, "roa_avg2y": 0.03218579379953731, "roa_period_end": 0.02833078101071975, "roe_avg2y": 0.06620739017625481, "roe_period_end": 0.058093892290783475 } }, { "accn": "0001564590-20-003773", "filed": "2022-02-11", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 24800000.0, "cash": 141714000.0, "eps_diluted": 0.22, "free_cash_flow": 76600000.0, "net_income": 21100000.0, "operating_cash_flow": 101400000.0, "operating_income": 36800000.0, "revenue": 451200000.0, "stockholders_equity": 480800000.0, "total_assets": 993151000.0, "total_liabilities": 512386000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.0656946755407655, "net_margin": 0.04676418439716312, "operating_margin": 0.08156028368794327, "revenue_growth_yoy": 1.7916300595201267, "roa_avg2y": 0.023305363215742496, "roa_period_end": 0.021245510501424255, "roe_avg2y": 0.04947245017584994, "roe_period_end": 0.043885191347753746 } }, { "accn": "0001564590-20-003773", "filed": "2021-02-05", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6940000.0, "cash": 254712000.0, "eps_diluted": -1.62, "free_cash_flow": -101271000.0, "net_income": -142542000.0, "operating_cash_flow": -94331000.0, "operating_income": -131361000.0, "revenue": 161626000.0, "stockholders_equity": 372200000.0, "total_assets": 817591000.0, "total_liabilities": 445453000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.1968108543793659, "net_margin": -0.8819249378194103, "operating_margin": -0.8127467115439347, "revenue_growth_yoy": 9.775066666666667, "roa_avg2y": -0.24104975407486576, "roa_period_end": -0.17434389566421352, "roe_avg2y": -0.4149229271246163, "roe_period_end": -0.38297152068780227 } }, { "accn": "0001564590-20-003773", "filed": "2020-02-07", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4108000.0, "cash": 83267000.0, "eps_diluted": -1.63, "free_cash_flow": -110289000.0, "net_income": -141090000.0, "operating_cash_flow": -106181000.0, "operating_income": -147372000.0, "revenue": 15000000.0, "stockholders_equity": 314877000.0, "total_assets": 365086000.0, "total_liabilities": 50209000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.15945591453170604, "roa_period_end": -0.3864568896095715, "roe_period_end": -0.44807972636934423 } } ], "latest_filing": { "accn": "0000914475-26-000007", "filed": "2026-02-11", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000914475.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000914475.json" }, "ticker": "NBIX" }